HIMSHims & Hers Health, Inc.
$30.88-47% 1Y
$30.88
$14.5252 weeks$62.76
The financials
Hims & Hers Health, Inc. by the numbers
Hims & Hers Health, Inc. (HIMS) reported revenue of $753M in Q2 2026 (quarter ended Jun 30, 2026), up 38% from the same quarter a year earlier. That came with a gross margin of 64% and net loss of $86M. For the full year FY2025, revenue was $2.35B (+59% year on year) and net income $128M. Its largest region in Q2 2026 was United States at $622M, 83% of the disclosed total, well ahead of Non Us at 17%. The next results filing is expected around Nov 2, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $753M | $545M | +38% |
| Gross profit | $481M | $416M | +16% |
| Operating income | −$97M | $27M | to a loss |
| Net income | −$86M | $43M | to a loss |
| Diluted EPS | −$0.37 | $0.17 | to a loss |
| Geographic | Revenue | Share |
|---|---|---|
| United States | $622M | 83% |
| Non Us | $131M | 17% |
Business segments
Revenue split by geographic segment, from SEC XBRL filings.
Latest period: Q2 2026Total $753.2M (+24%)
Segment Latestquarter on quarteryear on year
- United States$621.8M$621.8Mquarter on quarter +17%year on year +16%+17%+16%
- Non Us$131.4M$131.4Mquarter on quarter +68%year on year +1641%+68%+1641%
On our screens:Most shorted stocks
Drug Manufacturers, Specialty & Generic
Ranks #36 of 41 by RyuScore